Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus-Infected, and Uninfected Patients

被引:68
作者
Lim, Joseph K. [1 ,2 ]
Tate, Janet P. [1 ,2 ]
Fultz, Shawn L. [3 ]
Goulet, Joseph L. [1 ,2 ]
Conigliaro, Joseph [4 ]
Bryant, Kendall J. [5 ]
Gordon, Adam J. [6 ,7 ]
Gibert, Cynthia [8 ,9 ]
Rimland, David [10 ,11 ]
Goetz, Matthew Bidwell [12 ,13 ]
Klein, Marina B. [14 ]
Fiellin, David A. [2 ,15 ]
Justice, Amy C. [1 ,2 ,15 ]
Lo Re, Vincent, III [16 ,17 ]
机构
[1] Vet Affairs VA Connecticut Healthcare Syst, West Haven, CT USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] US FDA, Ctr Tobacco Prod, Washington, DC 20204 USA
[4] North Shore LIJ Hlth Syst, Lake Success, NY USA
[5] NIAAA, Bethesda, MD USA
[6] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[7] Pittsburgh VA Med Ctr, Pittsburgh, PA USA
[8] VA Med Ctr, Washington, DC USA
[9] George Washington Univ, Med Ctr, Washington, DC 20037 USA
[10] Atlanta VA Med Ctr, Atlanta, GA USA
[11] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[12] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[13] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[14] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada
[15] Yale Univ, Sch Publ Hlth, Yale Ctr Interdisciplinary Res AIDS, New Haven, CT USA
[16] Univ Penn, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA
[17] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
alcohol; liver fibrosis; HIV; hepatitis C; FIB-4; PLATELET RATIO INDEX; PREDICTING LIVER FIBROSIS; VETERANS AGING COHORT; ASPARTATE-AMINOTRANSFERASE; PSYCHIATRIC-DIAGNOSIS; SAMPLING VARIABILITY; CIRRHOSIS; VALIDATION; TESTS; FIB-4;
D O I
10.1093/cid/ciu097
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. It is unclear if the risk of liver disease associated with different levels of alcohol consumption is higher for patients infected with human immunodeficiency virus (HIV) or chronic hepatitis C virus (HCV). We evaluated associations between alcohol use categories and advanced hepatic fibrosis, by HIV and chronic HCV status. Methods. We performed a cross-sectional study among participants in the Veterans Aging Cohort Study who reported alcohol consumption at enrollment (701 HIV/HCV-coinfected; 1410 HIV-monoinfected; 296 HCV-monoinfected; 1158 HIV/HCV-uninfected). Alcohol use category was determined by the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) questionnaire and alcohol-related diagnoses and was classified as nonhazardous drinking, hazardous/binge drinking, or alcohol-related diagnosis. Advanced hepatic fibrosis was defined by FIB-4 index >3.25. Results. Within each HIV/HCV group, the prevalence of advanced hepatic fibrosis increased as alcohol use category increased. For each alcohol use category, advanced hepatic fibrosis was more common among HIV-infected than uninfected (nonhazardous: 6.7% vs 1.4%; hazardous/binge: 9.5% vs 3.0%; alcohol-related diagnosis: 19.0% vs 8.6%; P < .01) and chronic HCV-infected than uninfected (nonhazardous: 13.6% vs 2.5%; hazardous/binge: 18.2% vs 3.1%; alcohol-related diagnosis: 22.1% vs 6.5%; P < .01) participants. Strong associations with advanced hepatic fibrosis (adjusted odds ratio [95% confidence interval]) were observed among HIV/HCV-coinfected patients with nonhazardous drinking (14.2 [5.91-34.0]), hazardous/binge drinking (18.9 [7.98-44.8]), and alcohol-related diagnoses (25.2 [10.6-59.7]) compared with uninfected nonhazardous drinkers. Conclusions. Advanced hepatic fibrosis was present at low levels of alcohol consumption, increased with higher alcohol use categories, and was more prevalent among HIV-infected and chronic HCV-infected patients than uninfected individuals. All alcohol use categories were strongly associated with advanced hepatic fibrosis in HIV/HCV-coinfected patients.
引用
收藏
页码:1449 / 1458
页数:10
相关论文
共 60 条
[51]   Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study) [J].
Rosenthal, E. ;
Pialoux, G. ;
Bernard, N. ;
Pradier, C. ;
Rey, D. ;
Bentata, M. ;
Michelet, C. ;
Pol, S. ;
Perronne, C. ;
Cacoub, P. .
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (03) :183-188
[52]   Diagnostic accuracy of the aspartate aminotransferaseto-platelet ratio index for the prediction of hepatitis c-related fibrosis: A systematic review [J].
Shaheen, Abdel Aziz M. ;
Myers, Robert P. .
HEPATOLOGY, 2007, 46 (03) :912-921
[53]  
SHAPER AG, 1988, LANCET, V2, P1267
[54]   Antiretroviral drugs and liver injury [J].
Soriano, Vincent ;
Puoti, Massimo ;
Garcia-Gasco, Pilar ;
Rockstroh, Juergen K. ;
Benhamou, Yves ;
Barreiro, Pablo ;
McGovern, Barbara .
AIDS, 2008, 22 (01) :1-13
[55]   Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection [J].
Sterling, Richard K. ;
Lissen, Eduardo ;
Clumeck, Nathan ;
Sola, Ricard ;
Correa, Mendes Cassia ;
Montaner, Julio ;
Sulkowski, Mark S. ;
Torriani, Francesca J. ;
Dieterich, Doug T. ;
Thomas, David L. ;
Messinger, Diethelm ;
Nelson, Mark .
HEPATOLOGY, 2006, 43 (06) :1317-1325
[56]   Alcohol consumption and depressive symptoms over time: A longitudinal study of patients with and without HIV infection [J].
Sullivan, Lynn E. ;
Goulet, Joseph L. ;
Justice, Amy C. ;
Fiellin, David A. .
DRUG AND ALCOHOL DEPENDENCE, 2011, 117 (2-3) :158-163
[57]   Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel [J].
Thompson, Melanie A. ;
Aberg, Judith A. ;
Cahn, Pedro ;
Montaner, Julio S. G. ;
Rizzardini, Giuliano ;
Telenti, Amalio ;
Gatell, Jose M. ;
Guenthard, Huldrych F. ;
Hammer, Scott M. ;
Hirsch, Martin S. ;
Jacobsen, Donna M. ;
Reiss, Peter ;
Richman, Douglas D. ;
Volberding, Paul A. ;
Yeni, Patrick ;
Schooley, Robert T. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (03) :321-333
[58]   FIB-4: A simple, inexpensive and accurate marker of fibrosis in HCV-infected patients [J].
Vallet-Pichard, Anais ;
Mallet, Vincent ;
Pol, Stanislas .
HEPATOLOGY, 2006, 44 (03) :769-769
[59]   Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C [J].
Vergniol, Julien ;
Foucher, Juliette ;
Terrebonne, Eric ;
Bernard, Pierre-Henri ;
le Bail, Brigitte ;
Merrouche, Wassil ;
Couzigou, Patrice ;
de Ledinghen, Victor .
GASTROENTEROLOGY, 2011, 140 (07) :1970-U197
[60]   A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C [J].
Wai, CT ;
Greenson, JK ;
Fontana, RJ ;
Kalbfleisch, JD ;
Marrero, JA ;
Conjeevaram, HS ;
Lok, ASF .
HEPATOLOGY, 2003, 38 (02) :518-526